Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05658640
Title	HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies (HEM-iSMART D)
Acronym	HEM-iSMART D
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Princess Maxima Center for Pediatric Oncology
Indications	lymphoblastic lymphoma acute lymphoblastic leukemia
Therapies	Cyclophosphamide + Cytarabine + Dexamethasone + Trametinib
Age Groups:	adult \| child
Covered Countries	SWE \| NOR \| NLD \| ITA \| ISR \| IRL \| GBR \| FRA \| FIN \| ESP \| DNK \| DEU \| CHE \| BEL \| AUT